Neurolutions
Helping you reclaim your life after stroke
IpsiHand™ is an FDA-cleared non-invasive device for rehabilitation of upper extremity motor function after stroke.
About Neurolutions
Neurolutions is a medical technology company dedicated to transforming the lives of patients suffering from neurological conditions. Our mission is to develop innovative solutions that address the unmet needs of patients, and we are focused on advancing the field of neurorehabilitation through cutting-edge research and development.
About Neurolutions
Our flagship product, the IpsiHand device, is a breakthrough in neurorehabilitation that uses brain-computer interface technology to help patients regain hand function after stroke or other brain injuries. The IpsiHand device has been clinically validated and has received FDA clearance for use in the United States. At Neurolutions, we are committed to improving patient outcomes and providing exceptional customer service to our clients. We are a team of passionate individuals who share a common goal of making a difference in the lives of patients. If you are looking for a challenging and rewarding career in the medical technology industry.
IpsiHand is FDA Cleared - via De Novo
SBIR Awarded $2M to Neurolutions
First clinical trial complete. Published on Cover of Stroke
Reclaim Independence. Approximately 300,000 Americans each year suffer from post-stroke hemiparesis.
FDA Granted IpsiHand as a "Breakthrough Medical Technology"
First prescriptive orders for private pay home patients received
About Neurolutions
Neurolutions is a medical technology company dedicated to transforming the lives of patients suffering from neurological conditions. Our mission is to develop innovative solutions that address the unmet needs of patients, and we are focused on advancing the field of neurorehabilitation through cutting-edge research and development.
About Neurolutions
Our flagship product, the IpsiHand device, is a breakthrough in neurorehabilitation that uses brain-computer interface technology to help patients regain hand function after stroke or other brain injuries. The IpsiHand device has been clinically validated and has received FDA clearance for use in the United States. At Neurolutions, we are committed to improving patient outcomes and providing exceptional customer service to our clients. We are a team of passionate individuals who share a common goal of making a difference in the lives of patients. If you are looking for a challenging and rewarding career in the medical technology industry.
Board of Directors
IpsiHand is FDA Cleared - via De Novo
SBIR Awarded $2M to Neurolutions
First clinical trial complete. Published on Cover of Stroke
Reclaim Independence. Approximately 300,000 Americans each year suffer from post-stroke hemiparesis.
FDA Granted IpsiHand as a "Breakthrough Medical Technology"
First prescriptive orders for private pay home patients received
